Stay updated with breaking news from Passage Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sana Biotechnology (NASDAQ:SANA – Get Free Report) and Passage Bio (NASDAQ:PASG – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings. Volatility & Risk Sana Biotechnology has a […]
PHILADELPHIA, April 22, 2024 -- Passage Bio, Inc. , a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced that...
27.02.2024 - PHILADELPHIA, Feb. 27, 2024 (GLOBE NEWSWIRE) - Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced that management will ...
PHILADELPHIA, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced that
Passage Bio, Inc. (NASDAQ:PASG – Get Free Report) was the recipient of a significant decline in short interest in the month of January. As of January 15th, there was short interest totalling 316,300 shares, a decline of 17.6% from the December 31st total of 383,700 shares. Based on an average daily trading volume, of 626,300 […]